secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0001193125-22-304803
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres amends Cambridge lease: surrenders 14,760 sq ft, extends 68,636 sq ft to Jan 2030
--------------------------------------------------------------------------------

- Surrenders 14,760 rentable sq ft of office/lab space effective Nov 12, 2023.
- Extends lease on remaining 68,636 sq ft to Jan 13, 2030; initial rent $122/sq ft/yr with 3% annual escalations.
- Receives 2-month free rent at start of extension and $1.72M tenant improvement allowance ($25/sq ft).
- Rentable area after surrender: 68,636 sq ft; tenant's pro rata share in building becomes 36.39%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312522304803/0001193125-22-304803-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312522304803/d399120d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-304803

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer